Accepting the bioequivalence (BE) study report, the Subject Expert Committee (SEC) functional under the Central Drugs ...

MONTRÉAL, Aug. 21, 2025 (GLOBE NEWSWIRE) -- Morocco Strategic Minerals Corporation (TSXV: MCC) ("Morocco Strategic Minerals” ...

The Phase II VENTURE-Oral Dosing study of VK2735 met primary and secondary endpoints, with once-daily treatment leading to progressive weight reductions, high responder rates, and encouraging safety ...

Viking Therapeutics has reported phase 2 data on its oral obesity drug candidate, linking the peptide to weight loss of up to 12.2% after 13 weeks. But, with 38% of patients discontinuing treatment at ...

A study published in the journal Addiction found that young adults in the US do not reduce the amount of cannabis they consume when using higher-potency pr | Cannabis Sciences ...

Structure Therapeutics Inc. (NASDAQ:GPCR) is one of the best small cap stocks with biggest upside potential. On August 7, ...

Structure Therapeutics has dropped over 55% as its GLP-1 pill targets obesity, yet analysts remain bullish with high price ...

Nonin Medical has launched the Nonin Health platform, a cloud-based system to support clinicians, home care providers, independent diagnostic testing organizations (IDTFs), sleep dentists ...

Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people living with cancer, pain, dermatologic, ...

A daily dose of blarcamesine restored autophagy among patients with early Alzheimer’s disease, with improved outcomes through ...

While Mounjaro weight-loss injections can help with their waistlines, some users have reported issues with their hairlines ...

Noom introduces affordable options for obesity treatments, including Novo Nordisk's Wegovy and GLP-1Rx programs. Read more here.